These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28864456)

  • 21. Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay?
    Noer MC; Sperling CD; Ottesen B; Antonsen SL; Christensen IJ; Høgdall C
    Int J Gynecol Cancer; 2017 Jul; 27(6):1123-1133. PubMed ID: 28604447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
    Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
    Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
    Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
    Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of comorbidity on mortality in ovarian cancer patients.
    Stålberg K; Svensson T; Lönn S; Kieler H
    Gynecol Oncol; 2014 May; 133(2):298-303. PubMed ID: 24582801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometriosis-associated ovarian cancer: a different clinical entity.
    Leone Roberti Maggiore U; Bogani G; Paolini B; Martinelli F; Chiarello G; Spanò Bascio L; Chiappa V; Ferrero S; Ditto A; Raspagliesi F
    Int J Gynecol Cancer; 2024 Jun; 34(6):863-870. PubMed ID: 38531540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
    Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
    Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer?
    Dinkelspiel HE; Matrai C; Pauk S; Pierre-Louis A; Chiu YL; Gupta D; Caputo T; Ellenson LH; Holcomb K
    Cancer Invest; 2016; 34(3):148-54. PubMed ID: 26986692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.
    Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK
    Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
    Dixon SC; Nagle CM; Wentzensen N; Trabert B; Beeghly-Fadiel A; Schildkraut JM; Moysich KB; deFazio A; ; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Ness RB; Edwards RP; Jensen A; Kjær SK; Høgdall E; Berchuck A; Cramer DW; Terry KL; Poole EM; Bandera EV; Paddock LE; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Pike MC; Webb PM
    Br J Cancer; 2017 Apr; 116(9):1223-1228. PubMed ID: 28350790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival.
    Williams MG; Bandera EV; Demissie K; Rodríguez-Rodríguez L
    Obstet Gynecol; 2009 Apr; 113(4):783-789. PubMed ID: 19305320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma.
    Ren T; Wang S; Sun J; Qu JM; Xiang Y; Shen K; Lang JH
    J Ovarian Res; 2017 Oct; 10(1):67. PubMed ID: 28974236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
    O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
    J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
    Cannioto R; LaMonte MJ; Risch HA; Hong CC; Sucheston-Campbell LE; Eng KH; Brian Szender J; Chang-Claude J; Schmalfeldt B; Klapdor R; Gower E; Minlikeeva AN; Zirpoli GR; Bandera EV; Berchuck A; Cramer D; Doherty JA; Edwards RP; Fridley BL; Goode EL; Goodman MT; Hogdall E; Hosono S; Jensen A; Jordan S; ; Kjaer SK; Matsuo K; Ness RB; Olsen CM; Olson SH; Leigh Pearce C; Pike MC; Anne Rossing M; Szamreta EA; Thompson PJ; Tseng CC; Vierkant RA; Webb PM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Schildkraut JM; Terry KL; Kelemen LE; Moysich KB
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1114-24. PubMed ID: 27197285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.
    Kim HS; Kim TH; Chung HH; Song YS
    Br J Cancer; 2014 Apr; 110(7):1878-90. PubMed ID: 24518590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
    Cannioto RA; LaMonte MJ; Kelemen LE; Risch HA; Eng KH; Minlikeeva AN; Hong CC; Szender JB; Sucheston-Campbell L; Joseph JM; Berchuck A; Chang-Claude J; Cramer DW; DeFazio A; Diergaarde B; Dörk T; Doherty JA; Edwards RP; Fridley BL; Friel G; Goode EL; Goodman MT; Hillemanns P; Hogdall E; Hosono S; Kelley JL; Kjaer SK; Klapdor R; Matsuo K; Odunsi K; Nagle CM; Olsen CM; Paddock LE; Pearce CL; Pike MC; Rossing MA; Schmalfeldt B; Segal BH; Szamreta EA; Thompson PJ; Tseng CC; Vierkant R; Schildkraut JM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Ness RB; Jensen A; Webb PM; Terry K; Bandera EV; Moysich KB
    Br J Cancer; 2016 Jun; 115(1):95-101. PubMed ID: 27299959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.
    Mallen A; Todd S; Robertson SE; Kim J; Sehovic M; Wenham RM; Extermann M; Chon HS
    Gynecol Oncol; 2021 Jun; 161(3):693-699. PubMed ID: 33812698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
    Peres LC; Cushing-Haugen KL; Köbel M; Harris HR; Berchuck A; Rossing MA; Schildkraut JM; Doherty JA
    J Natl Cancer Inst; 2019 Jan; 111(1):60-68. PubMed ID: 29718305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
    Oza AM; Cook AD; Pfisterer J; Embleton A; Ledermann JA; Pujade-Lauraine E; Kristensen G; Carey MS; Beale P; Cervantes A; Park-Simon TW; Rustin G; Joly F; Mirza MR; Plante M; Quinn M; Poveda A; Jayson GC; Stark D; Swart AM; Farrelly L; Kaplan R; Parmar MK; Perren TJ;
    Lancet Oncol; 2015 Aug; 16(8):928-36. PubMed ID: 26115797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients.
    Wang S; Qiu L; Lang JH; Shen K; Huang HF; Pan LY; Wu M; Yang JX; Guo LN
    Am J Obstet Gynecol; 2013 Sep; 209(3):241.e1-9. PubMed ID: 23702297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.